Chemical modulation of bioactive compounds via oligopeptide or amino acid conjugation.

about

Chemical modulation of bioactive compounds via oligopeptide or amino acid conjugation.

Item

http://www.wikidata.org/entity/Q38124818

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Chemical modulation of bioactive compounds via oligopeptide or amino acid conjugation.

@en

type

Item

label

Chemical modulation of bioactive compounds via oligopeptide or amino acid conjugation.

@en

prefLabel

Chemical modulation of bioactive compounds via oligopeptide or amino acid conjugation.

@en

P1476

Chemical modulation of bioactive compounds via oligopeptide or amino acid conjugation.

@en

P2093

Jin-Kyoung Yang

http://www.w3.org/2001/XMLSchema#string

Jong-Ho Kim

http://www.w3.org/2001/XMLSchema#string

Seon-Yeong Kwak

http://www.w3.org/2001/XMLSchema#string

Yoon-Sik Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules

Paclitaxel derivatives for targeted therapy of cancer: toward the development of smart taxanes.

Novel peptide conjugates for tumor-specific chemotherapy.

A macromolecular prodrug of doxorubicin conjugated to a biodegradable cyclotriphosphazene bearing a tetrapeptide.

Amino acid conjugated sophorolipids: A new family of biologically active functionalized glycolipids.

Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.

A new daunomycin-peptide conjugate: synthesis, characterization and the effect on the protein expression profile of HL-60 cells in vitro.

Synthesis of new amino acid and peptide derivatives of estradiol and their binding affinities for the estrogen receptor.

Gene therapy for cardiovascular disease: a case for cautious optimism.

Development of a peptide-drug conjugate for prostate cancer therapy.

P304

584-591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIP.22307

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23893824

http://www.w3.org/2001/XMLSchema#string